Demand for quality medicines, health-related products and medical treatment has increased significantly in Russia in the past few years. Moreover, it is predicted to grow in the near future despite the current decline in disposable income. With the global pharmaceutical market forecast to double by 2020 to USD 1.8 trillion, there is a lot at stake for all players in this critical sector. Whether you are an international or Russian pharmaceutical company, you face many challenges that can affect your business’ growth strategy, both in the short and long term. Such challenges may include:
PwC has a dedicated team of pharma industry experts who can advise you on all of these issues. What’s more, they can provide practical assistance in such areas as developing a business strategy, resolving tax issues, raising finance, managing innovation, boosting operational efficiency, setting up risk management systems, and providing human resources solutions.
We are deeply committed to understanding the forces shaping our clients’ businesses so as to develop industry-tailored solutions and generate insights that provide a competitive advantage.